Omeros up 11% to $10.89 after AstraZeneca study failure
Omeros up 11% to $10.89 after AstraZeneca study failure
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.